NDC 49702-231

Triumeq

Abacavir Sulfate, Dolutegravir Sodium, Lamivudine

Triumeq is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Abacavir Sulfate; Dolutegravir Sodium; Lamivudine.

• Product ID: 49702-231_166cd280-b103-449c-8b8b-8210b994cc52
• NDC: 49702-231
• Product Type: Human Prescription Drug
• Proprietary Name: Triumeq
• Generic Name: Abacavir Sulfate, Dolutegravir Sodium, Lamivudine
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2014-08-22
• Marketing Category: NDA / NDA
• Application Number: NDA205551
• Labeler Name: ViiV Healthcare Company
• Substance Name: ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
• Active Ingredient Strength: 600 mg/1; mg/1; mg/1
• Pharm Classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 49702-231-13

30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)

• Marketing Start Date: 2014-08-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49702-231-13 [49702023113]

Triumeq TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA205551
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2014-08-22

Drug Details

Active Ingredients

Ingredient	Strength
ABACAVIR SULFATE	600 mg/1

OpenFDA Data

• SPL SET ID: 2997739a-aa91-42aa-a206-a70e2db7b84f
• Manufacturer:
  • ViiV Healthcare Company
• UNII:
  • J220T4J9Q2
  • 2T8Q726O95
  • 1Q1V9V5WYQ
• RxNorm Concept Unique ID - RxCUI:
  • 1546888
  • 1546894

Pharmacological Class

• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• HIV Integrase Inhibitors [MoA]
• Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
• Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
• Organic Cation Transporter 2 Inhibitors [MoA]
• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]

Medicade Reported Pricing

49702023113 TRIUMEQ 600-50-300 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Triumeq" or generic name "Abacavir Sulfate, Dolutegravir Sodium, Lamivudine"

NDC	Brand Name	Generic Name
49702-231	Triumeq	abacavir sulfate, dolutegravir sodium, lamivudine
50090-1606	Triumeq	abacavir sulfate, dolutegravir sodium, lamivudine
49702-258	Triumeq PD	abacavir sulfate, dolutegravir sodium, lamivudine